Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction

Fig. 1

The effectiveness of sema 3A-siRNA as determined by reduced protein and mRNA levels in vitro. a RT-PCR demonstrating sema 3A mRNA expression in rat myocardial cells transfected with sema 3A-shRNA 1 (SiRNA-1), 2 (SiRNA-2), and 3 (SiRNA-3), or PBS-control (Control) (*P < 0.01 vs. SiRNA-1). b, c Western blotting showing the expression of sema 3A in rat myocardial cells in various groups. (*P < 0.01 vs. SiRNA-1). d Image showing the effect of shRNA-3 in cultured rat myocardial cells using fluorescence microscopy

Back to article page